Sign In
Buy STK
$49.09
+0.94 (+1.95%)
At Close: Jul 31, 2026
BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine, today
Columbia Seligman Premium Technology Growth Fund Announces a First Quarter Distribution: 9.25% Annual Rate for IPO Investors
10:00am, Friday, 06'th Feb 2026
BOSTON--(BUSINESS WIRE)--Today, Columbia Seligman Premium Technology Growth Fund, Inc. (NYSE: STK) (the Fund) declared a first-quarter distribution, pursuant to its managed distribution policy, in the
STK: Tax-Efficient Income From The Growth Of AI
04:11pm, Tuesday, 03'rd Feb 2026
Columbia Seligman Premium Technology Growth Fund remains a strong buy, trading at a rare 3.97% NAV discount despite robust 12-month total returns of 31.7%. STK offers a compelling 6.8% dividend yield,
STK: A 5% Yield, Solid Long-Term Growth, And Deeper Discount
08:30am, Tuesday, 16'th Dec 2025
Columbia Seligman Premium Technology Growth Fund (STK) offers long-term capital appreciation and moderate income via a tech-focused, buy-write strategy with dynamic overwrite exposure. STK has deliver
Columbia Seligman Premium Technology Growth Fund Announces a Fourth Quarter Distribution
12:07pm, Friday, 07'th Nov 2025
BOSTON--(BUSINESS WIRE)--Today, Columbia Seligman Premium Technology Growth Fund, Inc. (NYSE: STK) (the Fund) declared a fourth quarter distribution, that is beyond its typical quarterly managed distr
Contrasting Shutterstock (NYSE:SSTK) & DHI Group (NYSE:DHX)
03:48am, Wednesday, 29'th Oct 2025
Shutterstock (NYSE: SSTK - Get Free Report) and DHI Group (NYSE: DHX - Get Free Report) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two
STK: 5% Yield, Historically Deep Discount
09:15am, Friday, 10'th Oct 2025
Columbia Seligman Premium Technology Growth Fund is a core holding for us, delivering strong returns and high, growing distributions via tech stocks and covered calls. STK currently trades at a 4.47%
10 Best CEFs This Month: Average Yield Of Nearly 9% (September 2025)
08:00am, Saturday, 27'th Sep 2025
For income investors, closed-end funds remain an attractive investment class that covers various asset classes and promises high distributions and reasonable total returns. Closed-end funds, or CEFs,
What Moved Markets This Week
06:45am, Saturday, 20'th Sep 2025
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
STK: The Most Attractive Valuation In A Decade (Rating Upgrade)
09:31am, Wednesday, 17'th Sep 2025
Columbia Seligman Premium Technology Growth Fund is upgraded to a strong buy, trading at a rare 3.8% discount to NAV. STK offers exposure to top technology growth companies and utilizes a dynamic cove
10 Best CEFs This Month: Average Yield Of Nearly 9% (August 2025)
08:05am, Saturday, 23'rd Aug 2025
For income investors, closed-end funds remain an attractive investment class that covers various asset classes and promises high distributions and reasonable total returns. Closed-end funds, or CEFs,
Columbia Seligman Premium Technology Growth Fund Announces a Third Quarter Distribution: 9.25% Annual Rate for IPO Investors
10:00am, Friday, 08'th Aug 2025
BOSTON--(BUSINESS WIRE)--Today, Columbia Seligman Premium Technology Growth Fund, Inc. (NYSE: STK) (the Fund) declared a third-quarter distribution, pursuant to its managed distribution policy, in the
How To Collect Dividends Up To 11% From Tech Stocks
10:30am, Sunday, 03'rd Aug 2025
The Nasdaq has been rallying nonstop since April. Let's discuss three covered call fund payouts up to 11.2% that play the rally.
A 13% Dividends From AI? Here Are The Tickers
05:30pm, Thursday, 31'st Jul 2025
By now you've no doubt heard the argument that AI is a bubble, and there's no way Big Tech will make a significant profit from it, given the massive amounts of cash they've already piled in.
STK: Stay Cautious With Elevated Valuations
11:02am, Friday, 11'th Jul 2025
STK's cautious stance and underweighting of megacap tech have led to recent underperformance but limit risk if valuations revert. Current market valuations are at bubble-like extremes, with limited up
